Surgery Partners (NASDAQ:SGRY) Sees Large Volume Increase – What’s Next?

Surgery Partners, Inc. (NASDAQ:SGRY) shares saw an uptick in trading volume on Wednesday. 6,326,966 shares traded hands during mid-day trading, an increase of 202% from the average daily volume of 2,098,303 shares. The stock last traded at $23.2250 and had previously closed at $23.13.

Key Surgery Partners News

Here are the key news stories impacting Surgery Partners this week:

• Positive Sentiment: The proposed cash acquisition provides a potential near-term exit price of $23.50 per share and is likely supporting SGRY’s valuation. Article: Wohl & Fruchter investigates proposed sale
• Neutral Sentiment: Several law firms announced investigations into whether the $23.50-per-share merger is fair to shareholders. These announcements raise the possibility of deal scrutiny or delay, but do not themselves indicate that the offer will change or that wrongdoing occurred. Article: BFA Law merger investigation Article: Monteverde merger investigation
• Negative Sentiment: TD Cowen cut its rating from “strong buy” to “hold,” removing a bullish analyst endorsement. Article: TD Cowen stock recommendations
• Negative Sentiment: KeyCorp lowered its earnings forecasts, projecting $0.07 per share for 2026 (previously $0.16) and a loss of $0.21 per share for 2027 (previously an expected profit of $0.13). The weaker outlook could weigh on sentiment, although the proposed sale is the more immediate focus. Article: Surgery Partners analyst estimates

Wall Street Analysts Forecast Growth

A number of research analysts have commented on the stock. Zacks Research cut shares of Surgery Partners from a “strong-buy” rating to a “hold” rating in a research note on Monday, August 10th. Cantor Fitzgerald lowered Surgery Partners from an “overweight” rating to a “hold” rating in a research note on Monday, October 26th. JPMorgan Chase & Co. increased their target price on Surgery Partners from $14.00 to $15.00 and gave the stock a “neutral” rating in a report on Monday, September 14th. Benchmark reissued a “buy” rating on shares of Surgery Partners in a report on Tuesday, August 11th. Finally, TD Cowen downgraded Surgery Partners from a “strong-buy” rating to a “hold” rating in a research report on Saturday. Three investment analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus target price of $20.14.

Surgery Partners Stock Up 0.1%

The firm has a market cap of $3.03 billion, a price-to-earnings ratio of -33.08 and a beta of 1.85. The company has a debt-to-equity ratio of 1.18, a quick ratio of 1.78 and a current ratio of 1.95. The business’s 50-day moving average is $15.49 and its 200-day moving average is $14.72.

Surgery Partners (NASDAQ:SGRY) last announced its quarterly earnings results on Monday, August 10th. The company reported $0.10 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.06 by $0.04. The firm had revenue of $848.90 million during the quarter, compared to the consensus estimate of $830.03 million. Surgery Partners had a negative net margin of 2.63% and a positive return on equity of 0.88%. The firm’s quarterly revenue was up 2.7% on a year-over-year basis. During the same period last year, the firm posted $0.17 EPS. On average, equities analysts predict that Surgery Partners, Inc. will post 0.22 EPS for the current year.

Insiders Place Their Bets

In other news, Director Teresa DeLuca acquired 10,000 shares of the company’s stock in a transaction dated Tuesday, August 18th. The stock was bought at an average price of $14.35 per share, with a total value of $143,500.00. Following the completion of the acquisition, the director owned 66,843 shares in the company, valued at approximately $959,197.05. This represents a 17.59% increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available through this hyperlink. Corporate insiders own 2.00% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently modified their holdings of the business. Public Employees Retirement System of Ohio bought a new stake in Surgery Partners during the 2nd quarter worth approximately $38,000. PNC Financial Services Group Inc. raised its position in Surgery Partners by 239.6% in the 1st quarter. PNC Financial Services Group Inc. now owns 2,907 shares of the company’s stock valued at $35,000 after purchasing an additional 2,051 shares during the last quarter. Fifth Third Bancorp raised its position in Surgery Partners by 5,324.0% in the 1st quarter. Fifth Third Bancorp now owns 4,068 shares of the company’s stock valued at $48,000 after purchasing an additional 3,993 shares during the last quarter. Empowered Funds LLC bought a new position in Surgery Partners in the 2nd quarter valued at $216,000. Finally, Vise Technologies Inc. acquired a new position in Surgery Partners in the third quarter worth $191,000.

Surgery Partners Company Profile

Surgery Partners, Inc is a U.S.-based healthcare services company that operates and manages ambulatory surgery centers and surgical hospitals. The company works with physicians, health systems and other healthcare providers to deliver outpatient surgical care in facilities designed for same-day procedures.

Its facilities provide surgical services across specialties such as orthopedics, pain management, ophthalmology, gastroenterology, urology, gynecology and general surgery. Surgery Partners also supports its operations with clinical, administrative and revenue-cycle services intended to help physicians and facility partners manage patient care and practice operations.

Founded in 2004 and headquartered in Brentwood, Tennessee, Surgery Partners has expanded its platform through acquisitions, joint ventures and other partnerships.